by Dr. David Ong
During the aging process there is ongoing bone resorption, fat loss and skin laxity changes. A common injectable biostimulator is poly-L-lactic acid (PLLA). It is considered a multifaceted product because it is used to address both volume loss and improvement in skin quality1,2.
Studies have demonstrated a statistically significant increase in skin elasticity, hydration, radiance and smoothness in PLLA-treated subjects1,2. There is also decreased pigmentation, erythema and pore size1. An improved glow or luminosity resulting from improved hydration, increase in skin thickness and improved skin laxity2 has also been described.
In 2004, Poly-L-lactic acid (Sculptra) was approved for the treatment of HIV-associated lipoatrophy by the FDA. In 2009, indications were expanded for the correction of shallow to deep nasolabial folds and other facial wrinkles in healthy patients (Sculptra Aesthetic)4. “Sculptra Luminosity” has been anecdotally described: the global improvement in skin quality following PLLA… To read more, click here.